Citation:Verbeek RE, van Oijen MG, ten Kate FJ, Vleggaar FP, Schipper ME, Casparie MK, et al 2012

From Cancer Guidelines Wiki

Citation


Verbeek RE, van Oijen MG, ten Kate FJ, Vleggaar FP, Schipper ME, Casparie MK, et al. Surveillance and follow-up strategies in patients with high-grade dysplasia in Barrett's esophagus: a Dutch population-based study. Am J Gastroenterol 2012 Apr 1;107(4):534-42 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/22270082.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What endoscopic surveillance protocol should be followed for patients with BO and high grade dysplasia?Dr Mark Appleyard MD FRACP MRCP MBBS BSccompleted
What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?Professor David Whiteman B Med Sci, MBBS (Hons) PhD FAFPHMcompleted
Are there groups of patients with non-dysplastic BO that require more frequent surveillance?Dr Henry Tocompleted
Are there groups of patients with BO that can be discharged from surveillance?Conjoint Associate Professor Philip Craigcompleted

Compare quality appraisals for each clinical question

Cited by

  1. Are there groups of patients with non-dysplastic BO that require more frequent surveillance?
  2. What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?
  3. What endoscopic surveillance protocol should be followed for patients with BO and high grade dysplasia?